Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia.

Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Volume: 102

Issue: 

Year of Publication: 2022

Affiliated Institutions:  National Center Chalbibelkahia of Pharmacovigilance of Tunis, Laboratory of Clinical Pharmacology, Boulevard Dr Zouhier Essafi, Tunis , Tunisia; University of Tunis El Manar, Faculty of Medicine of Tunis, LRSP, Tunis, Tunisia. Charles Nicolle Hospital, Laboratory of Microbiology, Virology unit, National Influenza and other Respiratory Viruses Center-Tunisia, Boulevard Avril, Tunis , Tunisia; University of Tunis El Manar, Faculty of Medicine of Tunis, LRES, Tunis, Tunisia. Electronic address: ferjsana@yahoo.fr. Department of Neurology, LRSP, Razi Universitary Hospital, rue des orangers Manouba, Tunis, Tunisia; Clinical Investigation Centre (CIC) "Neurosciences and Mental Health", Razi Universitary Hospital, rue des orangers Manouba, , Tunis, Tunisia. Laboratory of Bioinformatics, Biomathematics and Biostatistics-LRIPT, Institut Pasteur de Tunis, University of Tunis El Manar (UTM), Tunis, Tunisia. Ministry of Health, National Observatory of New and Emerging Diseases, Tunis, Tunisia. Charles Nicolle Hospital, Laboratory of Microbiology, Virology unit, National Influenza and other Respiratory Viruses Center-Tunisia, Boulevard Avril, Tunis , Tunisia. Department of Neurology, LRSP, Razi Universitary Hospital, rue des orangers Manouba, Tunis, Tunisia; Clinical Investigation Centre (CIC) "Neurosciences and Mental Health", Razi Universitary Hospital, rue des orangers Manouba, , Tunis, Tunisia; Faculty of Medicine of Tunis, University of Tunis El Manar, , Rue DjebelAkhdhar - La Rabta - , Tunis, Tunisia. University of Tunis El Manar, Faculty of Medicine of Tunis, LRES Human Genetics Laboratory, Tunis, Tunisia. National Center Chalbibelkahia of Pharmacovigilance of Tunis, Laboratory of Clinical Pharmacology, Boulevard Dr Zouhier Essafi, Tunis , Tunisia. Faculty of Medicine of Tunis, University of Tunis El Manar, , Rue DjebelAkhdhar - La Rabta - , Tunis, Tunisia; Abderrahmen Mami Hospital, Department of Medical Intensive Care, Ariana, Tunisia. Charles Nicolle Hospital, Laboratory of Microbiology, Virology unit, National Influenza and other Respiratory Viruses Center-Tunisia, Boulevard Avril, Tunis , Tunisia; University of Tunis El Manar, Faculty of Medicine of Tunis, LRES, Tunis, Tunisia.

Abstract summary 

Since the beginning of the Coronavirus disease-2019 pandemic, there has been a growing interest in exploring SARS-CoV-2 genetic variation to understand the origin and spread of the pandemic, improve diagnostic methods and develop the appropriate vaccines. The objective of this study was to identify the SARS-CoV-2s lineages circulating in Tunisia and to explore their amino acid signature in order to follow their genome dynamics. Whole genome sequencing and genetic analyses of fifty-eight SARS-CoV-2 samples collected during one-year between March 2020 and March 2021 from the National Influenza Center were performed using three sampling strategies.. Multiple lineage introductions were noted during the initial phase of the pandemic, including B.4, B.1.1, B.1.428.2, B.1.540 and B.1.1.189. Subsequently, lineages B1.160 (24.2%) and B1.177 (22.4%) were dominant throughout the year. The Alpha variant (B.1.1.7 lineage) was identified in February 2021 and firstly observed in the center of our country. In addition, A clear diversity of lineages was observed in the North of the country. A total of 335 mutations including 10 deletions were found. The SARS-CoV-2 proteins ORF1ab, Spike, ORF3a, and Nucleocapsid were observed as mutation hotspots with a mutation frequency exceeding 20%. The 2 most frequent mutations, D614G in S protein and P314L in Nsp12 appeared simultaneously and are often associated with increased viral infectivity. Interestingly, deletions in coding regions causing consequent deletions of amino acids and frame shifts were identified in NSP3, NSP6, S, E, ORF7a, ORF8 and N proteins. These findings contribute to define the COVID-19 outbreak in Tunisia. Despite the country's limited resources, surveillance of SARS-CoV-2 genomic variation should be continued to control the occurrence of new variants.

Authors & Co-authors:  Sassi Mouna Ben MB Ferjani Sana S Mkada Imen I Arbi Marwa M Safer Mouna M Elmoussi Awatef A Abid Salma S Souiai Oussema O Gharbi Alya A Tejouri Asma A Gaies Emna E Eljabri Hanene H Ayed Samia S Hechaichi Aicha A Daghfous Riadh R Gouider Riadh R Khelil Jalila Ben JB Kharrat Maher M Kacem Imen I Alya Nissaf Ben NB Benkahla Alia A Trabelsi Sameh S Boubaker Ilhem Boutiba-Ben IB

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Abid S., Ferjani S., El Moussi A., Ferjani A., Nasr M., Landolsi I., Saidi K., Gharbi H., Letaief H., Hechaichi A., Safer M., Ben Alaya N., Boubaker I.B. Assessment of sample pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia. Diagn. Microbiol. Infect. Dis. 2020;98(3) doi: 10.1016/j.diagmicrobio.2020.115125.
Authors :  23
Identifiers
Doi : 10.1016/j.meegid.2022.105300
SSN : 1567-7257
Study Population
Male,Female
Mesh Terms
Amino Acids
Other Terms
Amino acid change analysis;Amino acid signature;Coronavirus disease-2019;Lineages phylogenetic;SARS-CoV-2;Tunisia;Whole genome sequencing
Study Design
Case Control Trial,Cross Sectional Study
Study Approach
Country of Study
Tunisia
Publication Country
Netherlands